InsidersTradesSigma
Track the NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD stock price and the full directors' dealings record of the company, a listed equity based in Australia. Shares are listed on AU AU, under the authority of ASX. Market capitalisation: €24.9m. The latest transaction was filed on 3 June 2026 (Initial Substantial Holding). Among the most active insiders: 2. Details of voting power. The full history is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD is a biopharmaceutical company focused on developing treatments for neurological disorders. It is listed on the XASX market.